Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 – Roots Analysis

To order this detailed 500 page report, please visit this -https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html<br><br>Key Inclusions<br>uf0a7tA detailed assessment of the current market landscape featuring over 280 stem cell-based therapies approved / under clinical development, including information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters), phase of development (marketed, phase III, phase II, phase I), source of stem cells (allogeneic and autologous), origin of stem cells (adult and embryonic), type of stem cells (hematopoietic, mesenchymal, progenitor and others), stem cell lineage (amniotic fluid, adipose tissue, bone marrow, cardiosphere, chondrocytes, corneal tissue, cord blood, dental pulp, neural tissue placenta, peripheral blood, stromal cells and others), stem cell potency (multipotent and pluripotent), target indication(s), key therapeutic area(s), route of administration (intravenous, intramuscular, intraarticular, intramyocardial, intracoronary, intrathecal and others), and information on number of stem cells, special drug / therapy designation (if any), commercial geographical rights. In addition, information on the various technology platforms being actively used for the development of stem cell therapies has been provided<br>Contact Us<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com<br>

kevin987 + Follow